Table 2 Anticipated parental respondent visual analogue scale, willingness to pay and time trade off for each of the hypothetical four different febrile neutropaenia management strategies (N=155)

	Value	β ±s.e.	P- value
Median VAS score (IQR)			<0.0001^a
Inpatient	5.6 (2.8, 8.2)	REF	REF
Early discharge	5.9 (4.4, 7.2)	0.11±0.21	0.591
Outpatient i.v.	5.9 (4.4, 7.3)	0.06±0.26	0.804
Outpatient PO	4.7 (2.3, 7.2)	−0.81±0.37	0.030
Median WTP score (IQR) ^b			0.0001^a
Inpatient	0	REF	REF
Early discharge	50.0 (0.0, 200.0)	314.1±121.7	0.010
Outpatient i.v.	20.0 (0.0, 200.0)	224.2±50.6	<0.0001
Outpatient PO	0.0 (0.0, 200.0)	268.0±89.3	0.003
Median TTO presented as weeks given up (IQR)			0.464^a
Inpatient	0	REF	REF
Early discharge	0.0 (0.0, 0.0)	0.20±0.26	0.438
Outpatient i.v.	0.0 (0.0, 0.0)	−0.07±0.38	0.845
Outpatient PO	0.0 (0.0, 0.0)	−0.30±0.53	0.569

Abbreviations: IQR=interquartile range; i.v.=intravenous; PO=outpatient oral; REF=reference; TTO=time trade off; VAS=visual analogue scale; WTP=willingness to pay.
^aThese P-values represent differences across the four groups using repeated measures analysis.
^bIn Canadian dollars.

Quick links

Search